GUT MICROBIOTA AND PAIN EXPRESSION IN ANKYLOSING SPONDYLITIS: CLINICAL-MICROBIAL CORRELATES (GRASP-STUDY)
Advancements in Health Research · 06.05.2026 · 3 (s1)
DOI: 10.4081/ahr.2026.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advancements in Health Research, online erschienen am 06.05.2026. Verfasst von Fondazione Paolo Procacci. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Aims. Pain is the dominant clinical manifestation in ankylosing spondylitis (AS), reflecting both structural inflammation and neuroimmune mechanisms. Emerging evidence suggests that gut microbiota dysbiosis may contribute to systemic inflammation and pain amplification. This study aimed to evaluate the relationship between intestinal microbiota composition and pain expression in AS.
Methods
A cohort of 60 subjects (41 AS patients, 19 controls) was analyzed. Patients were stratified into axial (axAS) and peripheral (pAS) phenotypes. Clinical data included inflammatory markers and disease activity indices. Pain intensity was assessed indirectly through disease activity parameters. Gut microbiota composition was evaluated using PCR-based analysis, followed by multivariate and classification modeling.
Results
AS patients demonstrated a distinct microbial profile compared to controls (p < 0.001), with 12 predominant bacterial species identified versus 8 in controls. A significant reduction in Bacteroides (0.332 vs. 0.430) and marked increase in Prevotella (0.168 vs. 0.031) were observed, indicating dysbiosis associated with inflammatory activation. Patients with peripheral AS exhibited earlier disease onset (18.0 vs 25.5 years; p < 0.01) and higher inflammatory burden, corresponding to increased pain-related clinical expression. Multivariate analysis identified 8 microbial genera (including Dialister, Collinsella, and Streptococcus) as key discriminators of AS, with a classification accuracy of 95%, suggesting strong biological relevance. These taxa are known to induce pro-inflammatory pathways, supporting a mechanistic link between gut dysbiosis and nociceptive sensitization.
Conclusions
Gut microbiota alterations are associated with inflammatory activity and pain expression in AS. Microbial profiling may represent a novel biomarker for early identification of high-pain phenotypes and a potential therapeutic target.
Zitieren
APA
Procacci, F. P. (2026). GUT MICROBIOTA AND PAIN EXPRESSION IN ANKYLOSING SPONDYLITIS: CLINICAL-MICROBIAL CORRELATES (GRASP-STUDY). Advancements in Health Research, 3(s1). https://doi.org/10.4081/ahr.2026.155
Vancouver
Procacci FP. GUT MICROBIOTA AND PAIN EXPRESSION IN ANKYLOSING SPONDYLITIS: CLINICAL-MICROBIAL CORRELATES (GRASP-STUDY). Advancements in Health Research. 2026;3(s1). doi:10.4081/ahr.2026.155
BibTeX
@article{Procacci2026,
author = {Procacci, Fondazione Paolo},
title = {GUT MICROBIOTA AND PAIN EXPRESSION IN ANKYLOSING SPONDYLITIS: CLINICAL-MICROBIAL CORRELATES (GRASP-STUDY)},
journal = {Advancements in Health Research},
year = {2026},
volume = {3},
number = {s1},
doi = {10.4081/ahr.2026.155}
}
EUVIMED